<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04910373</url>
  </required_header>
  <id_info>
    <org_study_id>AL36</org_study_id>
    <nct_id>NCT04910373</nct_id>
  </id_info>
  <brief_title>Extensively Hydrolyzed Infant Formula in Infants and Children With Cow's Milk Allergy</brief_title>
  <official_title>Determination of Hypoallergenicity of an Extensively Hydrolyzed Infant Formula in Infants and Children With Cow's Milk Allergy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Nutrition</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Nutrition</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multi-center, randomized, double-blind, placebo-controlled food challenge to be&#xD;
      conducted in infants or children with confirmed IgE-mediated cow's milk allergy (CMA),&#xD;
      followed by a 7-day open feeding of the experimental formula.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">October 2021</start_date>
  <completion_date type="Anticipated">November 2024</completion_date>
  <primary_completion_date type="Anticipated">May 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Food Challenge Positive Reactions</measure>
    <time_frame>Food Challenge Day 1 to Food Challenge Day 2</time_frame>
    <description>Percent of positive food challenge reactions to the experimental formula</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Experimental Formula Intake</measure>
    <time_frame>Home Feeding Day 1 to Day 7</time_frame>
    <description>Parent completed diaries of formula intake</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Food Intake</measure>
    <time_frame>Home Feeding Day 1 to Day 7</time_frame>
    <description>Parent completed diaries</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gastrointestinal Symptoms</measure>
    <time_frame>Home Feeding Day 1 to Day 7</time_frame>
    <description>Parent completed diaries</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medication Use</measure>
    <time_frame>Home Feeding Day 1 to Day 7</time_frame>
    <description>Parent completed diaries</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Food Challenge Positive Reactions</measure>
    <time_frame>Home Feeding Day 1 to Day 7</time_frame>
    <description>Percent of positive food challenge reactions to the experimental formula</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">61</enrollment>
  <condition>Cow's Milk Allergy</condition>
  <arm_group>
    <arm_group_label>Experimental Extensively Hydrolyzed Formula</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Administered during food challenge and at home feeding period</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Extensively Hydrolyzed Formula</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Administered during food challenge</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Experimental Extensively Hydrolyzed Formula</intervention_name>
    <description>experimental powder formula</description>
    <arm_group_label>Experimental Extensively Hydrolyzed Formula</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo Extensively Hydrolyzed Formula</intervention_name>
    <description>placebo powder formula</description>
    <arm_group_label>Placebo Extensively Hydrolyzed Formula</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Participant has a physician diagnosis of IgE-mediated Cow's Milk Allergy (CMA) based&#xD;
             on a clinical history of a reaction resulting in characteristic immediate&#xD;
             hypersensitivity symptoms within 2 hours of oral exposure or immediate&#xD;
             hypersensitivity symptoms according to physician's observation&#xD;
&#xD;
          -  Participant is willing to undergo confirmatory testing or must have had at least one&#xD;
             of the following within 6 months of enrollment:&#xD;
&#xD;
               1. Documentation of milk-specific serum IgE &gt;15 kIUA/L or &gt; 5 kIUA/L if younger than&#xD;
                  1 year.&#xD;
&#xD;
               2. Documented cow's milk skin prick test mean wheal &gt;10mm&#xD;
&#xD;
               3. Physician-supervised oral food challenge that elicited immediate, objective,&#xD;
                  allergic symptoms.&#xD;
&#xD;
          -  Participant agrees to stop oral steroid use within 14 days and antihistamine use&#xD;
             within 7 days of confirmation of diagnosis and food challenges.&#xD;
&#xD;
          -  Participant had followed a strict cow's milk protein-free diet prior to enrollment.&#xD;
&#xD;
          -  Parent(s) confirm their intention not to administer any products containing cow's milk&#xD;
             protein during the study.&#xD;
&#xD;
          -  Participant's parent(s) has voluntarily signed and dated an Informed Consent Form&#xD;
             (ICF), approved by an Independent Ethics Committee/Institutional Review Board&#xD;
             (IEC/IRB) and provided Health Insurance Portability and Accountability Act (HIPAA) (or&#xD;
             other applicable privacy regulation) authorization prior to any participation in the&#xD;
             study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Participant is exclusively breastfed at the time of enrollment.&#xD;
&#xD;
          -  Participant is consuming an amino acid-based formula due to failure on an extensively&#xD;
             hydrolyzed formula.&#xD;
&#xD;
          -  Significant chronic medical diseases including major chromosomal or congenital&#xD;
             anomalies, gastrointestinal diseases or abnormalities other than CMA,&#xD;
             immunodeficiencies, unstable asthma, asthma treated with biologics (omalizumab or&#xD;
             other monoclonal antibody), FPIES, eosinophilic esophagitis, and severe uncontrolled&#xD;
             eczema.&#xD;
&#xD;
          -  Previous severe anaphylactic reaction to cow's milk within the last two years.&#xD;
&#xD;
          -  An adverse medical history or current condition that is thought by the investigator to&#xD;
             have potential for effects on tolerance or the hypoallergenicity test.&#xD;
&#xD;
          -  Participant has an allergy or intolerance to any ingredient in the study product, as&#xD;
             reported by the parent.&#xD;
&#xD;
          -  Participant is routinely consuming baked milk products.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Months</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carlett Ramirez</last_name>
    <role>Study Chair</role>
    <affiliation>Abbott Nutrition</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kristen DeLuca, MS, RDN, LDN</last_name>
    <phone>614-624-5455</phone>
    <email>kristen.deluca@abbott.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Children's Hospital Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Children's Healthcare of Atlanta</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30329</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>UNC-Chapel Hill</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Children's Hospital of Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>May 18, 2021</study_first_submitted>
  <study_first_submitted_qc>May 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 2, 2021</study_first_posted>
  <last_update_submitted>September 23, 2021</last_update_submitted>
  <last_update_submitted_qc>September 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypersensitivity</mesh_term>
    <mesh_term>Milk Hypersensitivity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

